Evidence map›Paper›PMID 19581879›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2009

A detailed characterization of the adult mouse model of glycogen storage disease Ia.

Susan V Salganik, David A Weinstein, Thomas D Shupe, Max Salganik, Dana G Pintilie, Bryon E Petersen

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Metabolic reprogramming by class I and II histone deacetylases.Trends in endocrinology and metabolism: TEM · 2013
    Review
  8. Article
  9. Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.Molecular therapy : the journal of the American Society of Gene Therapy · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Susan V SalganikDepartment of Pathology, Immunology and Laboratory Medicine and The Program for Stem Cell Biology and Regenerative Medicine, University of Florida College of Medicine, Gainesville, FL 32610-0275, USA.
David A Weinstein
Thomas D Shupe
Max Salganik
Dana G Pintilie
Bryon E Petersen
University of Florida · USFlorida College · US

Funding

Infrastructure for Population Research at PrincetonR24HD047879 · NICHD · PRINCETON UNIVERSITY · PI MASSEY, DOUGLAS S · 2004 to 2013
$7.3M
Mechanisms of Oval Cell Activation and DifferentiationR01DK058614 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PETERSEN, BRYON E · 2001 to 2014
$3.6M
Stem Cells in Liver Regeneration: Fusion or PlasticityR01DK065096 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PETERSEN, BRYON E · 2005 to 2013
$2.7M
NICHD NIH HHS R24 HD047879NIDDK NIH HHS R01 DK058614NIDDK NIH HHS R01 DK065096
6 · The paper itself

Abstract

Glycogen storage disease type Ia (GSDIa) is caused by a genetic defect in the hepatic enzyme glucose-6-phosphatase (G6Pase-alpha), which manifests as life-threatening hypoglycemia with related metabolic complications. A G6Pase-alpha knockout (KO) mouse model was generated to study potential therapies for correcting this disorder. Since then, gene therapy studies have produced promising results, showing long-term improvement in liver histology and glycogen metabolism. Under existing protocols, however, untreated KO pups seldom survived weaning. Here, we present a thorough characterization of the G6Pase-alpha KO mouse, as well as the husbandry protocol for rearing this strain to adulthood. These mice were raised with only palliative care, and characterized from birth through 6 months of age. Once KO mice have survived the very frail weaning period, their size, agility, serum lipids and glycemic control improve dramatically, reaching levels approaching their wild-type littermates. In addition, our data reveal that adult mice lacking G6Pase-alpha are able to mate and produce viable offspring. However, liver histology and glycogen accumulation do not improve with age. Overall, the reliable production of mature KO mice could provide a critical tool for advancing the GSDIa field, as the availability of a robust enzyme-deficient adult offers a new spectrum of treatment avenues that would not be tolerated by the frail pups. Most importantly, our detailed characterization of the adult KO mouse provides a crucial baseline for accurately gauging the efficacy of experimental therapies in this important model.

Indexed as

Glycogen Storage Disease Type IAnimal HusbandryAnimalsAnimals, NewbornAnimals, SucklingBlood Chemical AnalysisBody WeightDisease Models, AnimalFemaleFibrosisGlucose-6-PhosphataseGTP PhosphohydrolasesHypoglycemiaKidneyLiverLiver GlycogenGlucose-6-PhosphataseGTP PhosphohydrolasesLiver Glycogen

Identifiers

PMID19581879
PMCPMC3132560
OpenAlexW2072989205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.